Implementation of a TRIPS Waiver for Health Technologies and Products for COVID-19: Preventing Claims Under Free Trade and Investment Agreements

Carlos M. Correa, Nirmalya Syam, Daniel Uribe

Open source

DOI
10.2139/ssrn.4083056
Published
2023
Container
Not recorded
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2139/ssrn.4083056,
  title = {Implementation of a TRIPS Waiver for Health Technologies and Products for COVID-19: Preventing Claims Under Free Trade and Investment Agreements},
  author = {Carlos M. Correa and Nirmalya Syam and Daniel Uribe},
  year = {2023},
  doi = {10.2139/ssrn.4083056},
  url = {https://doi.org/10.2139/ssrn.4083056}
}

RIS

TY  - JOUR
TI  - Implementation of a TRIPS Waiver for Health Technologies and Products for COVID-19: Preventing Claims Under Free Trade and Investment Agreements
AU  - Carlos M. Correa
AU  - Nirmalya Syam
AU  - Daniel Uribe
PY  - 2023
DO  - 10.2139/ssrn.4083056
UR  - https://doi.org/10.2139/ssrn.4083056
ER  - 

APA

Correa, C. M., Syam, N., & Uribe, D. (2023). Implementation of a TRIPS Waiver for Health Technologies and Products for COVID-19: Preventing Claims Under Free Trade and Investment Agreements. https://doi.org/10.2139/ssrn.4083056

Source records